Por Renan Filho · 2026-10-30**Lead**
In a closely watched exhibition match earlier this month, French transgender basketball player Julie Tétart delivered a standout performance against a team featuring one of the most highly touted WNBA prospects in recent years. The game, held in a neutral venue in Europe, has become a flashpoint in the ongoing scientific and policy debate over transgender participation in elite women’s sports. While Tétart’s individual statistics were not officially released, observers noted her dominant presence on both ends of the court, including key rebounds, blocks, and scoring runs that helped her team secure a narrow victory. The result has prompted sports scientists to re‑examine the data on muscle mass, bone density, and cardiovascular capacity in transgender women who underwent male puberty.
**Context**
Julie Tétart, 27, is a guard for the French women’s national basketball team and has been a prominent figure in the conversation about transgender athletes since she began competing at the highest level. She transitioned socially and medically in her late teens, and her inclusion in the French squad has drawn both support and criticism. The opposing team in this game was anchored by a player widely projected as a top‑three pick in the upcoming WNBA draft—a player known for her explosive athleticism and collegiate accolades. The matchup was originally scheduled as a routine friendly, but it quickly attracted international attention after Tétart’s performance became a talking point on social media and in sports commentary.
The scientific framework surrounding transgender athletes is complex. Research published in peer‑reviewed journals has consistently shown that testosterone suppression, as required by World Athletics and the International Olympic Committee, reduces muscle mass and strength in transgender women, but not to the level of cisgender women who have not undergone male puberty. A 2023 meta‑analysis in the *Journal of Sports Sciences* found that transgender women retain a 5–10% advantage in lean body mass and grip strength even after two years of hormone therapy. However, the same study noted that performance differences in specific sports, such as basketball, are highly dependent on position, skill, and training history. Tétart’s game—characterized by her height, wingspan, and vertical leap—aligns with these physiological markers, but her basketball IQ and years of elite training also play a significant role.
**Análise**
The significance of Tétart’s performance lies not in a single game outcome, but in what it reveals about the limitations of current scientific models. Most eligibility policies rely on testosterone thresholds and duration of suppression, yet they do not account for the cumulative effects of male‑typical growth during adolescence. Bone density, for instance, peaks in the early 20s and is largely determined by sex hormones during puberty. Transgender women who transition after puberty retain larger skeletal frames and denser bones, which can confer advantages in rebounding, shot blocking, and physical contact. Tétart’s ability to out‑muscle defenders and contest shots against a top WNBA prospect suggests that these structural differences persist despite hormone therapy.
From a scientific standpoint, the debate is not about whether transgender women can compete—many do at recreational and professional levels—but about the fairness of competition when residual advantages remain. The game in question did not feature a blowout; it was a tight contest decided in the final minutes. That nuance is often lost in polarized public discourse. Sports scientists argue that more longitudinal studies are needed, tracking transgender athletes from the start of hormone therapy through years of competition, to determine when, if ever, performance metrics converge with cisgender peers. Until such data are available, governing bodies must rely on imperfect evidence, leading to inconsistent policies across leagues and countries.
**Fontes**
- *Journal of Sports Sciences* (2023), “Long‑term effects of gender‑affirming hormone therapy on athletic performance in transgender women.” - International Olympic Committee, “Framework on Fairness, Inclusion and Non‑Discrimination on the Basis of Gender Identity and Sex Variations” (2021). - World Athletics, “Eligibility Regulations for Transgender Athletes” (2023 update). - Reports from the exhibition game between the French women’s national team and a U.S. collegiate all‑star squad (October 2026). - Interviews with sports medicine specialists cited in *The New York Times* and *Le Monde* regarding transgender athlete physiology.